Company: PED
Filing Date: 2025-07-11
Form Type: DEF 14A
Source: 0001654954-25-007979
Chunk: 18

Company: PEDEVCO CORP
Filing Date: 2025-07-11
Form: DEF 14A
Chunk 18
---
isting of the following: (a) 460,000 shares of fully-vested common stock held by Mr. Evans; and (b) 85,000 unvested shares of common stock, which vest on September 27, 2025, provided that Mr. Evans remains a director, employee of, or consultant to us on such vesting date. Mr. Evans has voting control over his unvested shares of common stock.                                                                                                                                                                                                                                                                                                                                                                 |
| (8)  | Consisting of the following: (a) 349,500 shares of fully-vested common stock held by Mr. Scelfo; and (b) 125,000 unvested shares of common stock, which vest on July 12, 2025, provided that Mr. Scelfo remains a director, employee of, or consultant to us on such vesting date. Mr. Scelfo has voting control over his unvested shares of common stock.                                                                                                                                                                                                                                                                                                                                                                  |
| (9)  | Appointed as Director effective July 7, 2025. Consisting of 20,000 shares of fully-vested common stock held by Mr. Howie.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| (10) | Consisting of 51,791,325 shares of common stock held by The SGK 2018 Revocable Trust. The SGK 2018 Revocable Trust is a family trust of which Dr. Kukes is the trustee and beneficiary, and as such, Dr. Kukes is deemed to be the beneficial owner of the shares held by The SGK 2018 Revocable Trust.                                                                                                                                                                                                                                                                                                                                                                                                                     |

Changes in Control

The Company is not currently aware of any arrangements which may at a subsequent date result in a change of control of the Company.

| 10 |

<div align='center'>CORPORATE GOVERNANCE</div>

We promote accountability for adherence to honest and ethical conduct; endeavor to provide full, fair, accurate, timely and understandable disclosure in reports and documents that we file with the SEC and in other public communications made by us; and strive to be compliant with applicable governmental laws, rules and regulations.

Information regarding the members of and biographical information of our board of directors is provided below under “Proposal 1- Election of Directors”, beginning on page 40.

Board Leadership Structure

Our board of directors has the responsibility for selecting our appropriate leadership structure. In making leadership structure determinations, the board of directors considers